טוען...
The Effect of Selective c-MET Inhibitor on Hepatocellular Carcinoma in the MET-Active, β-Catenin-Mutated Mouse Model
Simultaneous mutations in CTNNB1 and activation of c-MET occur in 9%–12.5% of patients with hepatocellular carcinoma (HCC). Coexpression of c-MET-V5 and mutant β-catenin-Myc in mouse liver by sleeping beauty transposon/transposase and hydrodynamic tail vein injection (SB-HTVI) led to the development...
שמור ב:
| הוצא לאור ב: | Gene Expr |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Cognizant Communication Corporation
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5954626/ https://ncbi.nlm.nih.gov/pubmed/29409568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3727/105221618X15174108894682 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|